AD-O53.2-novel biological anticancer therapeutic agent with a dual mechanism of action

被引：0
|
作者：
Poleszak, K. [1 ]
Pieczykolan, J. [1 ]
Pawlak, S. [1 ]
Zerek, B. [1 ]
Rozga, P. [1 ]
Teska-Kaminska, M. [1 ]
Galazka, M. [1 ]
Szymanik, M. [1 ]
Jaworski, A. [1 ]
Pieczykolan, A. [1 ]
Bukato, K. [1 ]
Strozek, W. [1 ]
机构：
[1] Adamed Sp Zoo, Drug Discovery, Warsaw, Poland
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70645-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
519
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [21] Therapeutic Efficacy of Silvestrol, a Novel Protein Translation Inhibitor, as an Anticancer Agent for Cholangiocarcinoma
    Kogure, Takayuki
    Braconi, Chiara
    Lucas, David M.
    Grever, Michael
    Kinghorn, A. Douglas
    Patel, Tushar
    GASTROENTEROLOGY, 2011, 140 (05) : S913 - S913
  • [22] AD-O56.9: A fusion of TRAIL/Apo2L with a membrane disrupting peptide as a novel anticancer therapeutic
    Zerek, Bartlomiej Maciej
    Szymanik, Michal
    Rozga, Piotr Kamil
    Pieczykolan, Anna
    Galazka, Marlena
    Bukato, Katarzyna
    Jaworski, Albert
    Poleszak, Katarzyna
    Pawlak, Sebastian Dominik
    Teska-Kaminska, Malgorzata
    Strozek, Wojciech
    Pieczykolan, Jerzy Szczepan
    CANCER RESEARCH, 2014, 74 (19)
  • [23] The AD-O56.9-fusion of TRAIL/Apo2L with a membrane permeable peptide as a novel anticancer therapeutic
    Pieczykolan, J.
    Poleszak, K.
    Rozga, P.
    Pieczykolan, A.
    Galazka, M.
    Bukato, K.
    Szymanik, M.
    Jaworski, A.
    Pawlak, S.
    Zerek, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S107 - S108
  • [24] Design, Synthesis and Biological Evaluation of Novel anticancer agent Sprio Indolone Compounds
    Li, Jingyu
    Zhang, Xiaomin
    Song, Binbin
    Yu, Peng
    Lu, Kui
    ADVANCES IN CHEMICAL ENGINEERING III, PTS 1-4, 2013, 781-784 : 1240 - 1243
  • [25] Design, Synthesis and Biological Evaluation of Novel Tamibarotene Derivative as Multitarget Anticancer Agent
    Jiang, Yuqi
    Hou, Jinning
    Li, Xiaoyang
    Xu, Wenfang
    Zhang, Yingjie
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (08) : 729 - 733
  • [26] Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent
    Zhang, Lei
    Chen, Fan
    Zhang, Zeguo
    Chen, Yongzheng
    Wang, Jing
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (01) : 38 - 42
  • [27] Synthesis, characterization and biological evaluation of a novel vanadium complex as a possible anticancer agent
    Sinha, Abhinaba
    Banerjee, Kaushik
    Banerjee, Arpita
    Das, Satyajit
    Choudhuri, Soumitra Kumar
    JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2014, 772 : 34 - 41
  • [28] Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent
    Cirri, Damiano
    Massai, Lara
    Giacomelli, Chiara
    Trincavelli, Maria Letizia
    Guerri, Annalisa
    Gabbiani, Chiara
    Messori, Luigi
    Pratesi, Alessandro
    DALTON TRANSACTIONS, 2022, 51 (35) : 13527 - 13539
  • [29] CYCLOPROPAMITOSENES - NOVEL BIOREDUCTIVE ANTICANCER AGENTS - MECHANISM OF ACTION AND ENZYMATIC REDUCTION
    MOODY, CJ
    OSULLIVAN, N
    STRATFORD, IJ
    STEPHENS, MA
    WORKMAN, P
    BAILEY, SM
    LEWIS, A
    ANTI-CANCER DRUGS, 1994, 5 (03) : 367 - 372
  • [30] Novel Dual Action Peptide Therapeutic in Attenuation of Pulmonary Fibrosis
    Yang, D. C.
    Franzi, L.
    Hsu, S.
    Chen, C.
    Wu, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345